Response to Comment on Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic

Robert Goodnough; Karla Canseco

doi:10.1080/15563650.2020.1813298

Response to Comment on Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic

Producción científica: Letter › revisión exhaustiva

Idioma original	English (US)
Páginas (desde-hasta)	78-79
Número de páginas	2
Publicación	Clinical Toxicology
Volumen	59
N.º	1
DOI	https://doi.org/10.1080/15563650.2020.1813298
Estado	Published - 2021
Publicado de forma externa	Sí

ASJC Scopus subject areas

Toxicology

Acceder al documento

10.1080/15563650.2020.1813298

Otros archivos y enlaces

Citar esto

@article{6c853ce8d868418ea85cfd2d9a3097ee,

title = "Response to Comment on Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic",

author = "Robert Goodnough and Karla Canseco",

year = "2021",

doi = "10.1080/15563650.2020.1813298",

language = "English (US)",

volume = "59",

pages = "78--79",

journal = "Clinical Toxicology",

issn = "1556-3650",

publisher = "Taylor and Francis Ltd.",

number = "1",

}

TY - JOUR

T1 - Response to Comment on Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic

AU - Goodnough, Robert

AU - Canseco, Karla

PY - 2021

Y1 - 2021

UR - https://www.scopus.com/pages/publications/85090311691

UR - https://www.scopus.com/pages/publications/85090311691#tab=citedBy

U2 - 10.1080/15563650.2020.1813298

DO - 10.1080/15563650.2020.1813298

M3 - Letter

C2 - 32896174

AN - SCOPUS:85090311691

SN - 1556-3650

VL - 59

SP - 78

EP - 79

JO - Clinical Toxicology

JF - Clinical Toxicology

IS - 1

ER -